Study finds a screening byproduct, once thought to be clinically insignificant, is useful in predicting the likelihood of breast cancer in high-risk women
Seattle Cancer Care Alliance's Dr. Connie Lehman is corresponding author of updated guidelines that emphasize breast MRI to supplement standard imaging